The object of this program was to develop a method to irradiate primates with whole-body exposures to proton beams in the energy range from 5 to 28 MeV. A system to expand the external beam of the Oak Range Isochronous Cyclotron was devised. The spatial distribution of the beam was uniform within ±5% over a 20 × 40-cm rectangle, and for all energies above 5 MeV the energy resolution was less than 1.8 MeV full width at half maximum. The proton beam was extremely stable; all beam profiles were basically identical, and the center of the beam did not vary over 3 cm in any direction. A variable-volume ionization chamber was designed and fabricated for use in remotely measuring the relative intensity of the flux. Flux values were measured with a Faraday cup, and surface-dose calculations were made from tabulated values of 1/ρ dE/dX for muscle. The dose values were accurate within ±8% for all energies used except 5 MeV, where the energy straggling made the uncertainty ±10%. In all, 90 primates were irradiated at 28, 21, 14, or 5 MeV and given doses ranging from 500 to 2000 rads.
Skip Nav Destination
Close
Article navigation
1 February 1969
Research Article|
February 01 1969
Physical Dosimetry and Instrumentation for Low-Energy Proton Irradiation of Primates
Radiat Res (1969) 37 (2): 261–271.
Citation
Larry A. Boles, Kenneth R. Blake, C. Varren Parker,, John B. Nelson; Physical Dosimetry and Instrumentation for Low-Energy Proton Irradiation of Primates. Radiat Res 1 February 1969; 37 (2): 261–271. doi: https://doi.org/10.2307/3572729
Download citation file:
Close
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your InstitutionCiting articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner